Literature DB >> 15215554

Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques.

Karl-Friedrich Jakob Kreitner1, Sebastian Ley, Hans-Ulrich Kauczor, Eckhard Mayer, Thorsten Kramm, Michael Bernhard Pitton, Frank Krummenauer, Manfred Thelen.   

Abstract

PURPOSE: To evaluate the potential of breath-hold magnetic resonance (MR) imaging techniques in morphologic and functional assessment of patients with chronic thromboembolic pulmonary hypertension (CTEPH) before and after surgery.
MATERIALS AND METHODS: Thirty-four patients with CTEPH were examined before and after pulmonary thromboendarterectomy (PTE). For morphologic assessment, contrast material-enhanced MR angiography was used; for assessment of hemodynamics, velocity-encoded gradient-echo sequences and cine gradient-echo sequences along the short axis of the heart were performed. Contrast-enhanced MR angiography was compared with selective digital subtraction angiography (DSA) for depiction of central thromboembolic material and visualization of the pulmonary arterial tree. Functional analysis included calculation of left and right ventricular ejection fractions and peak velocities, net forward volumes per heartbeat, and blood volume per minute in the left and right pulmonary arteries and ascending aorta. Flow measurements were compared with invasively measured mean pulmonary arterial pressure (MPAP) and pulmonary vascular resistance (PVR) measurements. Nonparametric Wilcoxon and sign tests were used for statistical analysis.
RESULTS: MR angiography revealed typical findings of CTEPH (intraluminal webs and bands, vessel cutoffs, and organized central thromboemboli) in all patients. It depicted pulmonary vessels up to the segmental level in all cases. For subsegmental arteries, DSA revealed significantly more patent vessel segments than did MR angiography (733 versus 681 segments, P <.001). MR angiography revealed technical success of surgery in 33 of 34 patients. Patients had reduced right ventricular ejection fractions and pulmonary peak velocities that significantly increased after PTE (P <.001 for both). Right ventricular ejection fraction had good correlation with PVR (r = 0.6) and MPAP (r = 0.7). The postoperative decrease in MPAP correlated well with the increase in right ventricular ejection fraction (r = 0.8). Postoperatively, there was complete reduction of a preoperatively existing bronchosystemic shunt volume in 33 of 34 patients.
CONCLUSION: Breath-hold MR imaging techniques enable morphologic and semiquantitative functional assessment of patients with CTEPH. Copyright RSNA, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15215554     DOI: 10.1148/radiol.2322030945

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  33 in total

1.  Proton MRI appearance of cystic fibrosis: comparison to CT.

Authors:  Michael Puderbach; Monika Eichinger; Julie Gahr; Sebastian Ley; Siegfried Tuengerthal; Astrid Schmähl; Christian Fink; Christian Plathow; Matthias Wiebel; Frank-Michael Müller; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2006-08-29       Impact factor: 5.315

Review 2.  MR imaging of the pulmonary vasculature--an update.

Authors:  Mark R Pedersen; Mark T Fisher; Edwin J R van Beek
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

Review 3.  [MRI of pulmonary embolism].

Authors:  C Fink; S Thieme; S Ley; D Clevert; M F Reiser; H-U Kauczor; S O Schoenberg
Journal:  Radiologe       Date:  2007-08       Impact factor: 0.635

Review 4.  The role of 1.5T cardiac MRI in the diagnosis, prognosis and management of pulmonary arterial hypertension.

Authors:  Gianluca Marrone; Giuseppe Mamone; Angelo Luca; Patrizio Vitulo; Alessandro Bertani; Michele Pilato; Bruno Gridelli
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-25       Impact factor: 2.357

5.  Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension.

Authors:  Sebastian Ley; Derliz Mereles; Michael Puderbach; Ekkehard Gruenig; Helena Schöck; Monika Eichinger; Julia Ley-Zaporozhan; Christian Fink; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2007-01-16       Impact factor: 5.315

6.  Assessment of pulmonary thromboendarterectomy by tomographic electrocardiogram-gated equilibrium radionuclide angiocardiography compared with electron beam computed tomography.

Authors:  Ian P Clements; Brian P Mullan; Michael K O'Connor; Jerome F Breen; Christopher G A McGregor
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

7.  Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension.

Authors:  Smitha Rajaram; Andrew J Swift; David Capener; Adam Telfer; Christine Davies; Catherine Hill; Robin Condliffe; Charles Elliot; Judith Hurdman; David G Kiely; Jim M Wild
Journal:  Eur Radiol       Date:  2011-09-02       Impact factor: 5.315

8.  Evaluation of hemodynamic changes by use of phase-contrast MRI for patients with interstitial pneumonia, with special focus on blood flow reduction after breath-holding and bronchopulmonary shunt flow.

Authors:  Nanae Tsuchiya; Yuichiro Ayukawa; Sadayuki Murayama
Journal:  Jpn J Radiol       Date:  2012-12-20       Impact factor: 2.374

9.  Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension.

Authors:  Sebastian Ley; Christian Fink; Frank Risse; Nicola Ehlken; Christine Fischer; Julia Ley-Zaporozhan; Hans-Ulrich Kauczor; Hans Klose; Ekkehard Gruenig
Journal:  Eur Radiol       Date:  2012-08-12       Impact factor: 5.315

Review 10.  Contrast-enhanced CT- and MRI-based perfusion assessment for pulmonary diseases: basics and clinical applications.

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Ho Yun Lee; Sachiko Miura; Takeshi Yoshikawa; Kazuro Sugimura
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.